Vascular Neurologist, Allegheny Health Network

Russell Cerejo, MD

"If something is new everyone is excited about it. But it has to show that there is benefit to it. We, in our limited experience, were able to present our data and show that there is benefit to using it.”

 is a telehealth software that combines advanced imaging and workflow to enable physicians in hospital settings to make faster, more accurate triage and/or transfer decisions for patients who present with stroke. It allows teams to streamline workflows and coordinate care throughout the patient journey while also capturing data that may identify trends. RapidAI has been used in nearly 2000 hospitals worldwide and is approved in more than 100 countries.

Despite its success, some clinicians, including Russell Cerejo, MD, believe there is still untapped potential. Cerejo, a vascular neurologist at 

2022 International Stroke Conference (ISC)

, held February 9-11, in New Orleans, Louisiana, that featured the use of RapidAI. He and his colleagues showed that the software has relatively high sensitivity and very high specificity in detecting intracranial hemorrhage, as well as high accuracy in detecting high grade stenosis and large vessel occlusion.

Cerejo believes this is a system that can be implemented in various types of hospital settings, including ones that are smaller and rely on fewer staff, however, he believes that continued validation is also important. He sat down with 

to discuss the idea behind increasing applicability and expanding capabilities for RapidAI.

REFERENCES
1. Chang W, Eisenmenger L, Cerejo R, Li C, Goldberg MF. Artificial intelligence for automated detection of intracranial hemorrhage (Rapid ICH): initial clinical experience. Presented at: ISC 2022; February 9-11; New Orleans, LA. Poster WP129

Videos

The vascular neurologist at Allegheny Health Network discussed ways to grow the RapidAI software and the need to conduct additional, large-scale research. [WATCH TIME: 3 minutes]

Expanding the Applicability and Further Validating RapidAI: Russell Cerejo, MD

"We are able to be notified of the patients in the outlying hospitals with positive scans or large vessel occlusions as the scan gets done. By the time the radiologist is calling the emergency room, the emergency department is calling us for a transfer, we already are aware of this patient that may be potential candidate for an acute stroke therapy."

Delivered via mobile device, desktop and PACS, the Rapid clinical platform leverages artificial intelligence (AI) to create enhanced, high-quality images from NCCT, CTA, CTP, and MRI diffusion and perfusion data, to help physicians make expedient diagnoses and treatment and transfer decisions. Since its creation, 

 has been used in over 1800 hospitals, over 100 countries, and in 14 clinical trials globally.

The flexible platform is compatible in several different hospital environments, including emergency departments, trauma centers, acute stroke ready hospitals, primary stroke centers, and comprehensive stroke centers. Additionally, it was developed using the National Institutes of Standards and Technology cybersecurity framework and is also HIPAA and GDPR compliant. Considered the gold standard for advanced vascular imaging worldwide, RapidAI has been approved in several different countries outside of the US, including Canada and Japan.

Russell Cerejo, MD, vascular neurologist, Allegheny Health Network, has had first-hand experience using the software. Working in a large healthcare system, he believes there are several advantages brought on by RapidAI, led by its ability to improve multilevel communication. He sat down for an interview with 

® to outline the software and the benefits it brings to treat acute stroke.

The vascular neurologist at Allegheny Health Network provided an overview of the RapidAI and how it is evolving the way clinicians manage and treat patients who present with stroke. [WATCH TIME: 4 minutes]

Russell Cerejo, MD

Articles

Expanding the Applicability and Further Validating RapidAI: Russell Cerejo, MD

Capabilities, Advantages of RapidAI Software: Russell Cerejo, MD

Latest News